Andrew Clark

Andrew has been a consultant in paediatric allergy at Addenbrooke’s Hospital since 2002, gaining his Doctor of Medicine thesis in Allergy in the same year. He leads the paediatric allergy service at Addenbrooke's Hospital and his work is complemented by a broad UK Government-funded research portfolio in paediatric and adult allergy. Together with Pamela, Andrew led the recent successful Phase 1 and 2 trials in peanut oral immunotherapy that led to the foundation of Camallergy.

As key opinion leader in paediatric allergy practice, he also is chair of the Standards of Care Committee of the UK national professional allergy organisation (BSACI), leading the development of national guidelines for allergy specialists.